Stock Events

Regeneron Pharmaceuticals (REGN) Q2 2022 Earnings

4MayConfirmed
Q3 2021
Q4 2021
Q1 2022
Q2 2022
8.93
14.55
20.18
25.8

Details

Expected EPS
9.74
Actual EPS
8.93
Surprise EPS
-0.81
Surprise Percent
+8.32%

Description

Regeneron Pharmaceuticals (REGN) has reported earnings of 8.93 per share for Q2 2022.

0 Comments

Share your thoughts